nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—CYP1A2—Estropipate—osteoporosis	0.154	0.247	CbGbCtD
Phentermine—CYP2C9—Estropipate—osteoporosis	0.139	0.222	CbGbCtD
Phentermine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0729	0.117	CbGbCtD
Phentermine—CYP2C9—Cholecalciferol—osteoporosis	0.0715	0.115	CbGbCtD
Phentermine—CYP2D6—Cholecalciferol—osteoporosis	0.0654	0.105	CbGbCtD
Phentermine—CYP1A2—Estradiol—osteoporosis	0.064	0.102	CbGbCtD
Phentermine—CYP2C9—Estradiol—osteoporosis	0.0577	0.0923	CbGbCtD
Phentermine—Pseudoephedrine—NFATC1—osteoporosis	0.00979	0.768	CrCbGaD
Phentermine—Abdominal cramps—Estropipate—osteoporosis	0.00689	0.0215	CcSEcCtD
Phentermine—Abdominal cramps—Calcitriol—osteoporosis	0.00647	0.0202	CcSEcCtD
Phentermine—Cardiac arrest—Calcium Acetate—osteoporosis	0.00565	0.0177	CcSEcCtD
Phentermine—Abdominal cramps—Conjugated Estrogens—osteoporosis	0.00455	0.0142	CcSEcCtD
Phentermine—Abdominal cramps—Estradiol—osteoporosis	0.00364	0.0114	CcSEcCtD
Phentermine—Cerebrovascular accident—Estropipate—osteoporosis	0.00344	0.0108	CcSEcCtD
Phentermine—Cerebrovascular accident—Raloxifene—osteoporosis	0.00334	0.0104	CcSEcCtD
Phentermine—MAOB—Alpha-synuclein signaling—PARK7—osteoporosis	0.00311	0.0727	CbGpPWpGaD
Phentermine—Psychotic disorder—Calcitriol—osteoporosis	0.00309	0.00967	CcSEcCtD
Phentermine—Oedema—Calcium Acetate—osteoporosis	0.00292	0.00913	CcSEcCtD
Phentermine—Cerebrovascular accident—Ethinyl Estradiol—osteoporosis	0.00279	0.00873	CcSEcCtD
Phentermine—Hypertension—Ergocalciferol—osteoporosis	0.00273	0.00853	CcSEcCtD
Phentermine—Hallucination—Etidronic acid—osteoporosis	0.00269	0.00839	CcSEcCtD
Phentermine—Cardiac failure—Pamidronate—osteoporosis	0.0026	0.00812	CcSEcCtD
Phentermine—Acute coronary syndrome—Estropipate—osteoporosis	0.00256	0.00801	CcSEcCtD
Phentermine—Myocardial infarction—Estropipate—osteoporosis	0.00255	0.00797	CcSEcCtD
Phentermine—Constipation—Calcium Acetate—osteoporosis	0.0025	0.00781	CcSEcCtD
Phentermine—Psychotic disorder—Pamidronate—osteoporosis	0.00248	0.00774	CcSEcCtD
Phentermine—Cerebrovascular accident—Conjugated Estrogens—osteoporosis	0.00228	0.00711	CcSEcCtD
Phentermine—Angina pectoris—Risedronate—osteoporosis	0.00225	0.00702	CcSEcCtD
Phentermine—Constipation—Ergocalciferol—osteoporosis	0.00221	0.0069	CcSEcCtD
Phentermine—Asthenia—Calcium Acetate—osteoporosis	0.0021	0.00655	CcSEcCtD
Phentermine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.00208	0.0065	CcSEcCtD
Phentermine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00207	0.00646	CcSEcCtD
Phentermine—Diarrhoea—Calcium Acetate—osteoporosis	0.002	0.00625	CcSEcCtD
Phentermine—Tension—Estropipate—osteoporosis	0.00199	0.00623	CcSEcCtD
Phentermine—Nervousness—Estropipate—osteoporosis	0.00197	0.00617	CcSEcCtD
Phentermine—Dizziness—Calcium Acetate—osteoporosis	0.00193	0.00604	CcSEcCtD
Phentermine—Vomiting—Calcium Acetate—osteoporosis	0.00186	0.0058	CcSEcCtD
Phentermine—Asthenia—Ergocalciferol—osteoporosis	0.00185	0.00579	CcSEcCtD
Phentermine—Cerebrovascular accident—Estradiol—osteoporosis	0.00182	0.00569	CcSEcCtD
Phentermine—SLC6A3—Alpha-synuclein signaling—PARK7—osteoporosis	0.00181	0.0424	CbGpPWpGaD
Phentermine—Lacosamide—CA2—osteoporosis	0.0018	0.141	CrCbGaD
Phentermine—Palpitations—Estropipate—osteoporosis	0.0018	0.00561	CcSEcCtD
Phentermine—Agitation—Calcitriol—osteoporosis	0.00175	0.00548	CcSEcCtD
Phentermine—Nausea—Calcium Acetate—osteoporosis	0.00174	0.00542	CcSEcCtD
Phentermine—Palpitations—Ibandronate—osteoporosis	0.00172	0.00538	CcSEcCtD
Phentermine—Chest pain—Alendronate—osteoporosis	0.0017	0.00533	CcSEcCtD
Phentermine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00169	0.0053	CcSEcCtD
Phentermine—Dyspepsia—Etidronic acid—osteoporosis	0.00169	0.00528	CcSEcCtD
Phentermine—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.00168	0.00527	CcSEcCtD
Phentermine—Hypertension—Ibandronate—osteoporosis	0.00168	0.00526	CcSEcCtD
Phentermine—Chest pain—Raloxifene—osteoporosis	0.00168	0.00524	CcSEcCtD
Phentermine—Chest pain—Ibandronate—osteoporosis	0.00166	0.00519	CcSEcCtD
Phentermine—Oedema—Estropipate—osteoporosis	0.00166	0.00519	CcSEcCtD
Phentermine—Hypertension—Calcitriol—osteoporosis	0.00165	0.00515	CcSEcCtD
Phentermine—Constipation—Etidronic acid—osteoporosis	0.00164	0.00513	CcSEcCtD
Phentermine—Chest pain—Calcitriol—osteoporosis	0.00162	0.00508	CcSEcCtD
Phentermine—Dry mouth—Ibandronate—osteoporosis	0.00162	0.00507	CcSEcCtD
Phentermine—SLC6A4—Synaptic Vesicle Pathway—PARK7—osteoporosis	0.0016	0.0374	CbGpPWpGaD
Phentermine—Dry mouth—Calcitriol—osteoporosis	0.00159	0.00497	CcSEcCtD
Phentermine—SLC6A3—Parkinsons Disease Pathway—PARK7—osteoporosis	0.00154	0.036	CbGpPWpGaD
Phentermine—Nausea—Ergocalciferol—osteoporosis	0.00153	0.00479	CcSEcCtD
Phentermine—Urticaria—Etidronic acid—osteoporosis	0.00152	0.00476	CcSEcCtD
Phentermine—Abdominal pain—Etidronic acid—osteoporosis	0.00152	0.00474	CcSEcCtD
Phentermine—Insomnia—Estropipate—osteoporosis	0.0015	0.00469	CcSEcCtD
Phentermine—Tension—Pamidronate—osteoporosis	0.0015	0.00468	CcSEcCtD
Phentermine—Nervousness—Pamidronate—osteoporosis	0.00148	0.00464	CcSEcCtD
Phentermine—Dyspepsia—Estropipate—osteoporosis	0.00146	0.00456	CcSEcCtD
Phentermine—Insomnia—Raloxifene—osteoporosis	0.00145	0.00454	CcSEcCtD
Phentermine—Insomnia—Ibandronate—osteoporosis	0.00144	0.0045	CcSEcCtD
Phentermine—Dyspepsia—Alendronate—osteoporosis	0.00144	0.0045	CcSEcCtD
Phentermine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00143	0.00448	CcSEcCtD
Phentermine—Fatigue—Estropipate—osteoporosis	0.00143	0.00447	CcSEcCtD
Phentermine—Constipation—Estropipate—osteoporosis	0.00142	0.00443	CcSEcCtD
Phentermine—Dyspepsia—Raloxifene—osteoporosis	0.00141	0.00442	CcSEcCtD
Phentermine—Insomnia—Calcitriol—osteoporosis	0.00141	0.0044	CcSEcCtD
Phentermine—Agitation—Pamidronate—osteoporosis	0.0014	0.00439	CcSEcCtD
Phentermine—Dyspepsia—Ibandronate—osteoporosis	0.0014	0.00438	CcSEcCtD
Phentermine—Constipation—Alendronate—osteoporosis	0.0014	0.00437	CcSEcCtD
Phentermine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00139	0.00434	CcSEcCtD
Phentermine—Hypertension—Risedronate—osteoporosis	0.00139	0.00434	CcSEcCtD
Phentermine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00137	0.00429	CcSEcCtD
Phentermine—Fatigue—Ibandronate—osteoporosis	0.00137	0.00429	CcSEcCtD
Phentermine—Chest pain—Risedronate—osteoporosis	0.00137	0.00427	CcSEcCtD
Phentermine—Constipation—Ibandronate—osteoporosis	0.00136	0.00425	CcSEcCtD
Phentermine—Acute coronary syndrome—Estradiol—osteoporosis	0.00136	0.00424	CcSEcCtD
Phentermine—Myocardial infarction—Estradiol—osteoporosis	0.00135	0.00421	CcSEcCtD
Phentermine—Oedema—Ethinyl Estradiol—osteoporosis	0.00134	0.0042	CcSEcCtD
Phentermine—Dry mouth—Risedronate—osteoporosis	0.00134	0.00418	CcSEcCtD
Phentermine—SLC6A4—Monoamine Transport—TNFRSF11B—osteoporosis	0.00133	0.0312	CbGpPWpGaD
Phentermine—Constipation—Calcitriol—osteoporosis	0.00133	0.00416	CcSEcCtD
Phentermine—Hypertension—Pamidronate—osteoporosis	0.00132	0.00412	CcSEcCtD
Phentermine—Tension—Conjugated Estrogens—osteoporosis	0.00132	0.00412	CcSEcCtD
Phentermine—Urticaria—Estropipate—osteoporosis	0.00132	0.00412	CcSEcCtD
Phentermine—Diarrhoea—Etidronic acid—osteoporosis	0.00131	0.0041	CcSEcCtD
Phentermine—Abdominal pain—Estropipate—osteoporosis	0.00131	0.0041	CcSEcCtD
Phentermine—Tremor—Zoledronate—osteoporosis	0.00131	0.00408	CcSEcCtD
Phentermine—Nervousness—Conjugated Estrogens—osteoporosis	0.0013	0.00408	CcSEcCtD
Phentermine—Urticaria—Alendronate—osteoporosis	0.0013	0.00406	CcSEcCtD
Phentermine—Abdominal pain—Alendronate—osteoporosis	0.00129	0.00404	CcSEcCtD
Phentermine—Agitation—Zoledronate—osteoporosis	0.00128	0.00401	CcSEcCtD
Phentermine—Abdominal pain—Raloxifene—osteoporosis	0.00127	0.00397	CcSEcCtD
Phentermine—Urticaria—Ibandronate—osteoporosis	0.00126	0.00395	CcSEcCtD
Phentermine—Abdominal pain—Ibandronate—osteoporosis	0.00126	0.00393	CcSEcCtD
Phentermine—Oedema—Pamidronate—osteoporosis	0.00125	0.0039	CcSEcCtD
Phentermine—Urticaria—Calcitriol—osteoporosis	0.00124	0.00387	CcSEcCtD
Phentermine—Palpitations—Zoledronate—osteoporosis	0.00123	0.00385	CcSEcCtD
Phentermine—Abdominal pain—Calcitriol—osteoporosis	0.00123	0.00385	CcSEcCtD
Phentermine—Vomiting—Etidronic acid—osteoporosis	0.00122	0.00381	CcSEcCtD
Phentermine—Tachycardia—Pamidronate—osteoporosis	0.00122	0.0038	CcSEcCtD
Phentermine—Rash—Etidronic acid—osteoporosis	0.00121	0.00378	CcSEcCtD
Phentermine—Dermatitis—Etidronic acid—osteoporosis	0.00121	0.00378	CcSEcCtD
Phentermine—Hypertension—Zoledronate—osteoporosis	0.0012	0.00376	CcSEcCtD
Phentermine—Headache—Etidronic acid—osteoporosis	0.0012	0.00375	CcSEcCtD
Phentermine—Asthenia—Estropipate—osteoporosis	0.00119	0.00372	CcSEcCtD
Phentermine—Chest pain—Zoledronate—osteoporosis	0.00119	0.00371	CcSEcCtD
Phentermine—Palpitations—Conjugated Estrogens—osteoporosis	0.00119	0.00371	CcSEcCtD
Phentermine—Insomnia—Risedronate—osteoporosis	0.00119	0.00371	CcSEcCtD
Phentermine—Asthenia—Alendronate—osteoporosis	0.00117	0.00366	CcSEcCtD
Phentermine—Dry mouth—Zoledronate—osteoporosis	0.00116	0.00363	CcSEcCtD
Phentermine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00116	0.00363	CcSEcCtD
Phentermine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00116	0.00362	CcSEcCtD
Phentermine—Dyspepsia—Risedronate—osteoporosis	0.00115	0.00361	CcSEcCtD
Phentermine—Constipation—Ethinyl Estradiol—osteoporosis	0.00115	0.00359	CcSEcCtD
Phentermine—Pseudoephedrine—TNF—osteoporosis	0.00115	0.0902	CrCbGaD
Phentermine—SLC6A2—Monoamine Transport—TNFRSF11B—osteoporosis	0.00115	0.0268	CbGpPWpGaD
Phentermine—Chest pain—Conjugated Estrogens—osteoporosis	0.00114	0.00357	CcSEcCtD
Phentermine—Asthenia—Ibandronate—osteoporosis	0.00114	0.00357	CcSEcCtD
Phentermine—Nausea—Etidronic acid—osteoporosis	0.00114	0.00356	CcSEcCtD
Phentermine—Oedema—Zoledronate—osteoporosis	0.00114	0.00356	CcSEcCtD
Phentermine—Diarrhoea—Estropipate—osteoporosis	0.00114	0.00355	CcSEcCtD
Phentermine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00113	0.00354	CcSEcCtD
Phentermine—Fatigue—Risedronate—osteoporosis	0.00113	0.00353	CcSEcCtD
Phentermine—Insomnia—Pamidronate—osteoporosis	0.00113	0.00352	CcSEcCtD
Phentermine—Constipation—Risedronate—osteoporosis	0.00112	0.0035	CcSEcCtD
Phentermine—Diarrhoea—Alendronate—osteoporosis	0.00112	0.00349	CcSEcCtD
Phentermine—Asthenia—Calcitriol—osteoporosis	0.00112	0.00349	CcSEcCtD
Phentermine—Tachycardia—Zoledronate—osteoporosis	0.00111	0.00347	CcSEcCtD
Phentermine—Diarrhoea—Raloxifene—osteoporosis	0.0011	0.00344	CcSEcCtD
Phentermine—Dyspepsia—Pamidronate—osteoporosis	0.0011	0.00343	CcSEcCtD
Phentermine—Dizziness—Estropipate—osteoporosis	0.0011	0.00343	CcSEcCtD
Phentermine—Oedema—Conjugated Estrogens—osteoporosis	0.0011	0.00343	CcSEcCtD
Phentermine—SLC6A4—Circadian rythm related genes—ID4—osteoporosis	0.00109	0.0255	CbGpPWpGaD
Phentermine—Diarrhoea—Ibandronate—osteoporosis	0.00109	0.0034	CcSEcCtD
Phentermine—Dizziness—Alendronate—osteoporosis	0.00108	0.00338	CcSEcCtD
Phentermine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00108	0.00336	CcSEcCtD
Phentermine—Fatigue—Pamidronate—osteoporosis	0.00107	0.00336	CcSEcCtD
Phentermine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00107	0.00334	CcSEcCtD
Phentermine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00107	0.00334	CcSEcCtD
Phentermine—Constipation—Pamidronate—osteoporosis	0.00107	0.00333	CcSEcCtD
Phentermine—Diarrhoea—Calcitriol—osteoporosis	0.00107	0.00333	CcSEcCtD
Phentermine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00106	0.00332	CcSEcCtD
Phentermine—Dizziness—Raloxifene—osteoporosis	0.00106	0.00332	CcSEcCtD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00106	0.0248	CbGpPWpGaD
Phentermine—Tension—Estradiol—osteoporosis	0.00105	0.0033	CcSEcCtD
Phentermine—Vomiting—Estropipate—osteoporosis	0.00105	0.0033	CcSEcCtD
Phentermine—Dizziness—Ibandronate—osteoporosis	0.00105	0.00329	CcSEcCtD
Phentermine—Rash—Estropipate—osteoporosis	0.00105	0.00327	CcSEcCtD
Phentermine—Dermatitis—Estropipate—osteoporosis	0.00105	0.00327	CcSEcCtD
Phentermine—Nervousness—Estradiol—osteoporosis	0.00104	0.00326	CcSEcCtD
Phentermine—Urticaria—Risedronate—osteoporosis	0.00104	0.00326	CcSEcCtD
Phentermine—Headache—Estropipate—osteoporosis	0.00104	0.00325	CcSEcCtD
Phentermine—Vomiting—Alendronate—osteoporosis	0.00104	0.00325	CcSEcCtD
Phentermine—Abdominal pain—Risedronate—osteoporosis	0.00104	0.00324	CcSEcCtD
Phentermine—Rash—Alendronate—osteoporosis	0.00103	0.00322	CcSEcCtD
Phentermine—Insomnia—Zoledronate—osteoporosis	0.00103	0.00322	CcSEcCtD
Phentermine—Dermatitis—Alendronate—osteoporosis	0.00103	0.00322	CcSEcCtD
Phentermine—Headache—Alendronate—osteoporosis	0.00102	0.0032	CcSEcCtD
Phentermine—Vomiting—Raloxifene—osteoporosis	0.00102	0.00319	CcSEcCtD
Phentermine—SLC6A3—Monoamine Transport—TNFRSF11B—osteoporosis	0.00101	0.0237	CbGpPWpGaD
Phentermine—Rash—Raloxifene—osteoporosis	0.00101	0.00317	CcSEcCtD
Phentermine—Dermatitis—Raloxifene—osteoporosis	0.00101	0.00316	CcSEcCtD
Phentermine—Vomiting—Ibandronate—osteoporosis	0.00101	0.00316	CcSEcCtD
Phentermine—Tremor—Estradiol—osteoporosis	0.00101	0.00315	CcSEcCtD
Phentermine—Headache—Raloxifene—osteoporosis	0.00101	0.00315	CcSEcCtD
Phentermine—SLC6A3—Dopaminergic Neurogenesis—WNT1—osteoporosis	0.001	0.0235	CbGpPWpGaD
Phentermine—Rash—Ibandronate—osteoporosis	0.001	0.00314	CcSEcCtD
Phentermine—Dermatitis—Ibandronate—osteoporosis	0.001	0.00313	CcSEcCtD
Phentermine—Dyspepsia—Zoledronate—osteoporosis	0.001	0.00313	CcSEcCtD
Phentermine—Headache—Ibandronate—osteoporosis	0.000997	0.00312	CcSEcCtD
Phentermine—Insomnia—Conjugated Estrogens—osteoporosis	0.000992	0.0031	CcSEcCtD
Phentermine—Vomiting—Calcitriol—osteoporosis	0.00099	0.00309	CcSEcCtD
Phentermine—Agitation—Estradiol—osteoporosis	0.000988	0.00309	CcSEcCtD
Phentermine—Nausea—Estropipate—osteoporosis	0.000985	0.00308	CcSEcCtD
Phentermine—Abdominal pain—Pamidronate—osteoporosis	0.000985	0.00308	CcSEcCtD
Phentermine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000983	0.00307	CcSEcCtD
Phentermine—Rash—Calcitriol—osteoporosis	0.000982	0.00307	CcSEcCtD
Phentermine—Fatigue—Zoledronate—osteoporosis	0.000982	0.00307	CcSEcCtD
Phentermine—Dermatitis—Calcitriol—osteoporosis	0.000981	0.00307	CcSEcCtD
Phentermine—Headache—Calcitriol—osteoporosis	0.000976	0.00305	CcSEcCtD
Phentermine—Constipation—Zoledronate—osteoporosis	0.000974	0.00304	CcSEcCtD
Phentermine—Nausea—Alendronate—osteoporosis	0.000971	0.00303	CcSEcCtD
Phentermine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000965	0.00302	CcSEcCtD
Phentermine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000965	0.00302	CcSEcCtD
Phentermine—Nausea—Raloxifene—osteoporosis	0.000955	0.00298	CcSEcCtD
Phentermine—Palpitations—Estradiol—osteoporosis	0.00095	0.00297	CcSEcCtD
Phentermine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000946	0.00296	CcSEcCtD
Phentermine—Fatigue—Conjugated Estrogens—osteoporosis	0.000945	0.00295	CcSEcCtD
Phentermine—Nausea—Ibandronate—osteoporosis	0.000945	0.00295	CcSEcCtD
Phentermine—Asthenia—Risedronate—osteoporosis	0.000941	0.00294	CcSEcCtD
Phentermine—Constipation—Conjugated Estrogens—osteoporosis	0.000937	0.00293	CcSEcCtD
Phentermine—Hypertension—Estradiol—osteoporosis	0.000928	0.0029	CcSEcCtD
Phentermine—Nausea—Calcitriol—osteoporosis	0.000925	0.00289	CcSEcCtD
Phentermine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00092	0.00288	CcSEcCtD
Phentermine—Chest pain—Estradiol—osteoporosis	0.000915	0.00286	CcSEcCtD
Phentermine—SLC6A4—Serotonin Transporter Activity—IL1B—osteoporosis	0.00091	0.0213	CbGpPWpGaD
Phentermine—Urticaria—Zoledronate—osteoporosis	0.000904	0.00283	CcSEcCtD
Phentermine—Abdominal pain—Zoledronate—osteoporosis	0.0009	0.00281	CcSEcCtD
Phentermine—Diarrhoea—Risedronate—osteoporosis	0.000897	0.0028	CcSEcCtD
Phentermine—Dry mouth—Estradiol—osteoporosis	0.000895	0.0028	CcSEcCtD
Phentermine—Asthenia—Pamidronate—osteoporosis	0.000894	0.00279	CcSEcCtD
Phentermine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000889	0.00278	CcSEcCtD
Phentermine—Oedema—Estradiol—osteoporosis	0.000877	0.00274	CcSEcCtD
Phentermine—Urticaria—Conjugated Estrogens—osteoporosis	0.000871	0.00272	CcSEcCtD
Phentermine—Dizziness—Risedronate—osteoporosis	0.000867	0.00271	CcSEcCtD
Phentermine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000867	0.00271	CcSEcCtD
Phentermine—Tachycardia—Estradiol—osteoporosis	0.000856	0.00268	CcSEcCtD
Phentermine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000855	0.00267	CcSEcCtD
Phentermine—Diarrhoea—Pamidronate—osteoporosis	0.000853	0.00267	CcSEcCtD
Phentermine—MAOB—Tryptophan metabolism—CYP19A1—osteoporosis	0.000848	0.0198	CbGpPWpGaD
Phentermine—Rash—Ethinyl Estradiol—osteoporosis	0.000848	0.00265	CcSEcCtD
Phentermine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000847	0.00265	CcSEcCtD
Phentermine—Headache—Ethinyl Estradiol—osteoporosis	0.000842	0.00263	CcSEcCtD
Phentermine—Vomiting—Risedronate—osteoporosis	0.000834	0.00261	CcSEcCtD
Phentermine—Rash—Risedronate—osteoporosis	0.000827	0.00258	CcSEcCtD
Phentermine—Dermatitis—Risedronate—osteoporosis	0.000826	0.00258	CcSEcCtD
Phentermine—Dizziness—Pamidronate—osteoporosis	0.000824	0.00258	CcSEcCtD
Phentermine—Headache—Risedronate—osteoporosis	0.000821	0.00257	CcSEcCtD
Phentermine—Asthenia—Zoledronate—osteoporosis	0.000817	0.00255	CcSEcCtD
Phentermine—Nausea—Ethinyl Estradiol—osteoporosis	0.000799	0.0025	CcSEcCtD
Phentermine—Insomnia—Estradiol—osteoporosis	0.000794	0.00248	CcSEcCtD
Phentermine—Vomiting—Pamidronate—osteoporosis	0.000792	0.00248	CcSEcCtD
Phentermine—Asthenia—Conjugated Estrogens—osteoporosis	0.000787	0.00246	CcSEcCtD
Phentermine—Rash—Pamidronate—osteoporosis	0.000786	0.00246	CcSEcCtD
Phentermine—Dermatitis—Pamidronate—osteoporosis	0.000785	0.00245	CcSEcCtD
Phentermine—Headache—Pamidronate—osteoporosis	0.000781	0.00244	CcSEcCtD
Phentermine—Diarrhoea—Zoledronate—osteoporosis	0.000779	0.00243	CcSEcCtD
Phentermine—Nausea—Risedronate—osteoporosis	0.000779	0.00243	CcSEcCtD
Phentermine—Dyspepsia—Estradiol—osteoporosis	0.000772	0.00241	CcSEcCtD
Phentermine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000757	0.00237	CcSEcCtD
Phentermine—Fatigue—Estradiol—osteoporosis	0.000756	0.00236	CcSEcCtD
Phentermine—Dizziness—Zoledronate—osteoporosis	0.000753	0.00235	CcSEcCtD
Phentermine—Constipation—Estradiol—osteoporosis	0.00075	0.00234	CcSEcCtD
Phentermine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00075	0.00234	CcSEcCtD
Phentermine—MAOA—Serotonin Transporter Activity—IL1B—osteoporosis	0.000746	0.0174	CbGpPWpGaD
Phentermine—Nausea—Pamidronate—osteoporosis	0.00074	0.00231	CcSEcCtD
Phentermine—Dizziness—Conjugated Estrogens—osteoporosis	0.000725	0.00227	CcSEcCtD
Phentermine—Vomiting—Zoledronate—osteoporosis	0.000724	0.00226	CcSEcCtD
Phentermine—Rash—Zoledronate—osteoporosis	0.000718	0.00224	CcSEcCtD
Phentermine—Dermatitis—Zoledronate—osteoporosis	0.000717	0.00224	CcSEcCtD
Phentermine—Headache—Zoledronate—osteoporosis	0.000713	0.00223	CcSEcCtD
Phentermine—Vomiting—Conjugated Estrogens—osteoporosis	0.000697	0.00218	CcSEcCtD
Phentermine—Urticaria—Estradiol—osteoporosis	0.000697	0.00218	CcSEcCtD
Phentermine—Abdominal pain—Estradiol—osteoporosis	0.000694	0.00217	CcSEcCtD
Phentermine—Rash—Conjugated Estrogens—osteoporosis	0.000691	0.00216	CcSEcCtD
Phentermine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000691	0.00216	CcSEcCtD
Phentermine—Headache—Conjugated Estrogens—osteoporosis	0.000687	0.00215	CcSEcCtD
Phentermine—Nausea—Zoledronate—osteoporosis	0.000676	0.00211	CcSEcCtD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000664	0.0155	CbGpPWpGaD
Phentermine—Nausea—Conjugated Estrogens—osteoporosis	0.000651	0.00204	CcSEcCtD
Phentermine—MAOA—Oxidative Stress—SOD2—osteoporosis	0.000639	0.015	CbGpPWpGaD
Phentermine—Asthenia—Estradiol—osteoporosis	0.000629	0.00197	CcSEcCtD
Phentermine—MAOA—Oxidative Stress—GPX1—osteoporosis	0.00061	0.0143	CbGpPWpGaD
Phentermine—Diarrhoea—Estradiol—osteoporosis	0.0006	0.00188	CcSEcCtD
Phentermine—Dizziness—Estradiol—osteoporosis	0.00058	0.00181	CcSEcCtD
Phentermine—MAOB—Biological oxidations—CYP27A1—osteoporosis	0.000562	0.0132	CbGpPWpGaD
Phentermine—Vomiting—Estradiol—osteoporosis	0.000558	0.00174	CcSEcCtD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000556	0.013	CbGpPWpGaD
Phentermine—Rash—Estradiol—osteoporosis	0.000553	0.00173	CcSEcCtD
Phentermine—Dermatitis—Estradiol—osteoporosis	0.000553	0.00173	CcSEcCtD
Phentermine—Headache—Estradiol—osteoporosis	0.00055	0.00172	CcSEcCtD
Phentermine—Nausea—Estradiol—osteoporosis	0.000521	0.00163	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000388	0.00909	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—IL1B—osteoporosis	0.000387	0.00906	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.00036	0.00843	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000357	0.00834	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000354	0.00827	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP27A1—osteoporosis	0.000353	0.00825	CbGpPWpGaD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000352	0.00823	CbGpPWpGaD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000349	0.00816	CbGpPWpGaD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000349	0.00816	CbGpPWpGaD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000334	0.00782	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—IL1B—osteoporosis	0.000333	0.00779	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000318	0.00745	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000302	0.00707	CbGpPWpGaD
Phentermine—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000298	0.00698	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—CYP19A1—osteoporosis	0.000295	0.00691	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—IL1B—osteoporosis	0.000295	0.0069	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000289	0.00676	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000287	0.00671	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—TNF—osteoporosis	0.000281	0.00657	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000269	0.0063	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000256	0.00598	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000245	0.00573	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—TNF—osteoporosis	0.000242	0.00565	CbGpPWpGaD
Phentermine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—osteoporosis	0.000241	0.00565	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000221	0.00516	CbGpPWpGaD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000219	0.00511	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—TNF—osteoporosis	0.000214	0.00501	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—AGER—osteoporosis	0.000211	0.00494	CbGpPWpGaD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.00021	0.0049	CbGpPWpGaD
Phentermine—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000196	0.00459	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000187	0.00438	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000186	0.00434	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP19A1—osteoporosis	0.000185	0.00434	CbGpPWpGaD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000185	0.00433	CbGpPWpGaD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000183	0.00429	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—AGER—osteoporosis	0.000182	0.00425	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—POMC—osteoporosis	0.000177	0.00415	CbGpPWpGaD
Phentermine—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000175	0.00409	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PKM—osteoporosis	0.000167	0.00392	CbGpPWpGaD
Phentermine—MAOB—Metabolism—FDPS—osteoporosis	0.000167	0.00392	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—AGER—osteoporosis	0.000161	0.00377	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000159	0.00371	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GPD2—osteoporosis	0.000159	0.00371	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PGLS—osteoporosis	0.000159	0.00371	CbGpPWpGaD
Phentermine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000157	0.00366	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000155	0.00362	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000154	0.00359	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000152	0.00356	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000152	0.00355	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000151	0.00354	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000151	0.00352	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.00015	0.00351	CbGpPWpGaD
Phentermine—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.00015	0.0035	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ATIC—osteoporosis	0.000145	0.0034	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PNP—osteoporosis	0.000145	0.0034	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000143	0.00335	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—LEP—osteoporosis	0.00014	0.00327	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000137	0.0032	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000134	0.00314	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000131	0.00307	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.00013	0.00304	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000129	0.00301	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000128	0.003	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000125	0.00292	CbGpPWpGaD
Phentermine—MAOB—Metabolism—OXCT1—osteoporosis	0.000123	0.00289	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CA2—osteoporosis	0.000123	0.00289	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MGLL—osteoporosis	0.00012	0.00281	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000117	0.00275	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000113	0.00263	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000112	0.00261	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—POMC—osteoporosis	0.000111	0.00261	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000109	0.00255	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PKM—osteoporosis	0.000105	0.00246	CbGpPWpGaD
Phentermine—MAOA—Metabolism—FDPS—osteoporosis	0.000105	0.00246	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—ADCY5—osteoporosis	0.000103	0.00241	CbGpPWpGaD
Phentermine—MAOB—Metabolism—IDH2—osteoporosis	0.000102	0.00239	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000102	0.00238	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PGLS—osteoporosis	9.96e-05	0.00233	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GPD2—osteoporosis	9.96e-05	0.00233	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.65e-05	0.00226	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP27A1—osteoporosis	9.61e-05	0.00225	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—ADCY5—osteoporosis	9.56e-05	0.00224	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.54e-05	0.00223	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ACP5—osteoporosis	9.35e-05	0.00219	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.13e-05	0.00214	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ATIC—osteoporosis	9.11e-05	0.00213	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PNP—osteoporosis	9.11e-05	0.00213	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.05e-05	0.00212	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL1B—osteoporosis	8.94e-05	0.00209	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—TGFB1—osteoporosis	8.93e-05	0.00209	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	8.75e-05	0.00205	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.7e-05	0.00203	CbGpPWpGaD
Phentermine—MAOB—Metabolism—TPI1—osteoporosis	8.69e-05	0.00203	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.25e-05	0.00193	CbGpPWpGaD
Phentermine—MAOB—Metabolism—P4HB—osteoporosis	8.17e-05	0.00191	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	8.07e-05	0.00189	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GAPDH—osteoporosis	8.02e-05	0.00188	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	8e-05	0.00187	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	7.96e-05	0.00186	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TNF—osteoporosis	7.91e-05	0.00185	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	7.89e-05	0.00185	CbGpPWpGaD
Phentermine—MAOB—Metabolism—RAP1A—osteoporosis	7.81e-05	0.00183	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CA2—osteoporosis	7.74e-05	0.00181	CbGpPWpGaD
Phentermine—MAOA—Metabolism—OXCT1—osteoporosis	7.74e-05	0.00181	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.73e-05	0.00181	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—TGFB1—osteoporosis	7.68e-05	0.0018	CbGpPWpGaD
Phentermine—MAOA—Metabolism—MGLL—osteoporosis	7.55e-05	0.00177	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.5e-05	0.00176	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.31e-05	0.00171	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	6.83e-05	0.0016	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	6.82e-05	0.0016	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—TGFB1—osteoporosis	6.8e-05	0.00159	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	6.8e-05	0.00159	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	6.74e-05	0.00158	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TNF—osteoporosis	6.48e-05	0.00152	CbGpPWpGaD
Phentermine—MAOA—Metabolism—IDH2—osteoporosis	6.42e-05	0.0015	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.41e-05	0.0015	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL6—osteoporosis	6.38e-05	0.00149	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	6.35e-05	0.00149	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	6.35e-05	0.00149	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ENO1—osteoporosis	6.32e-05	0.00148	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.25e-05	0.00146	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PSMA2—osteoporosis	6.22e-05	0.00146	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PSMA5—osteoporosis	6.22e-05	0.00146	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP27A1—osteoporosis	6.03e-05	0.00141	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ACP5—osteoporosis	5.87e-05	0.00137	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.85e-05	0.00137	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.8e-05	0.00136	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TPI1—osteoporosis	5.46e-05	0.00128	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	5.23e-05	0.00122	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—IL6—osteoporosis	5.21e-05	0.00122	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.14e-05	0.0012	CbGpPWpGaD
Phentermine—MAOA—Metabolism—P4HB—osteoporosis	5.13e-05	0.0012	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP19A1—osteoporosis	5.05e-05	0.00118	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GAPDH—osteoporosis	5.03e-05	0.00118	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5e-05	0.00117	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.97e-05	0.00116	CbGpPWpGaD
Phentermine—MAOA—Metabolism—RAP1A—osteoporosis	4.9e-05	0.00115	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—POMC—osteoporosis	4.85e-05	0.00113	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—POMC—osteoporosis	4.81e-05	0.00112	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—FDPS—osteoporosis	4.57e-05	0.00107	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PKM—osteoporosis	4.57e-05	0.00107	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PKM—osteoporosis	4.53e-05	0.00106	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—FDPS—osteoporosis	4.53e-05	0.00106	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PGLS—osteoporosis	4.33e-05	0.00101	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GPD2—osteoporosis	4.33e-05	0.00101	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PGLS—osteoporosis	4.3e-05	0.00101	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GPD2—osteoporosis	4.3e-05	0.00101	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.25e-05	0.000994	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ADCY5—osteoporosis	4.13e-05	0.000965	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GPX1—osteoporosis	4.11e-05	0.000962	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—POMC—osteoporosis	4.11e-05	0.000961	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PNP—osteoporosis	3.96e-05	0.000928	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ATIC—osteoporosis	3.96e-05	0.000928	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ENO1—osteoporosis	3.96e-05	0.000927	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ATIC—osteoporosis	3.93e-05	0.00092	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PNP—osteoporosis	3.93e-05	0.00092	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PSMA2—osteoporosis	3.91e-05	0.000914	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PSMA5—osteoporosis	3.91e-05	0.000914	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—FDPS—osteoporosis	3.87e-05	0.000906	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PKM—osteoporosis	3.87e-05	0.000906	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MTHFR—osteoporosis	3.79e-05	0.000888	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PGLS—osteoporosis	3.67e-05	0.000859	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GPD2—osteoporosis	3.67e-05	0.000859	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CA2—osteoporosis	3.37e-05	0.000789	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—OXCT1—osteoporosis	3.37e-05	0.000789	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ATIC—osteoporosis	3.36e-05	0.000786	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PNP—osteoporosis	3.36e-05	0.000786	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CA2—osteoporosis	3.34e-05	0.000782	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—OXCT1—osteoporosis	3.34e-05	0.000782	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MGLL—osteoporosis	3.29e-05	0.000769	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MGLL—osteoporosis	3.26e-05	0.000762	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP19A1—osteoporosis	3.17e-05	0.000741	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.07e-05	0.000718	CbGpPWpGaD
Phentermine—MAOB—Metabolism—POMC—osteoporosis	3.04e-05	0.00071	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CA2—osteoporosis	2.86e-05	0.000668	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—OXCT1—osteoporosis	2.86e-05	0.000668	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—IDH2—osteoporosis	2.79e-05	0.000653	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MGLL—osteoporosis	2.78e-05	0.000651	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—IDH2—osteoporosis	2.77e-05	0.000648	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.63e-05	0.000614	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.62e-05	0.000614	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.6e-05	0.000609	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ADCY5—osteoporosis	2.59e-05	0.000606	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GPX1—osteoporosis	2.58e-05	0.000604	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ACP5—osteoporosis	2.55e-05	0.000598	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ACP5—osteoporosis	2.53e-05	0.000593	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.5e-05	0.000585	CbGpPWpGaD
Phentermine—MAOA—Metabolism—MTHFR—osteoporosis	2.38e-05	0.000557	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TPI1—osteoporosis	2.38e-05	0.000556	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—IDH2—osteoporosis	2.37e-05	0.000554	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TPI1—osteoporosis	2.35e-05	0.000551	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—P4HB—osteoporosis	2.23e-05	0.000522	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.22e-05	0.000521	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—P4HB—osteoporosis	2.21e-05	0.000518	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.19e-05	0.000513	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GAPDH—osteoporosis	2.17e-05	0.000508	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ACP5—osteoporosis	2.16e-05	0.000506	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.14e-05	0.0005	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—RAP1A—osteoporosis	2.13e-05	0.000499	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—RAP1A—osteoporosis	2.12e-05	0.000495	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TPI1—osteoporosis	2.01e-05	0.000471	CbGpPWpGaD
Phentermine—MAOA—Metabolism—POMC—osteoporosis	1.9e-05	0.000446	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—P4HB—osteoporosis	1.89e-05	0.000443	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.86e-05	0.000434	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.85e-05	0.000432	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.81e-05	0.000423	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ENO1—osteoporosis	1.73e-05	0.000404	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ENO1—osteoporosis	1.71e-05	0.0004	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.7e-05	0.000398	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.7e-05	0.000398	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.69e-05	0.000394	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.69e-05	0.000394	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.58e-05	0.000369	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ENO1—osteoporosis	1.46e-05	0.000342	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.44e-05	0.000337	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.44e-05	0.000337	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.38e-05	0.000323	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.37e-05	0.00032	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.17e-05	0.000273	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.13e-05	0.000264	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GPX1—osteoporosis	1.12e-05	0.000263	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ADCY5—osteoporosis	1.12e-05	0.000261	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GPX1—osteoporosis	1.11e-05	0.000261	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.04e-05	0.000243	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MTHFR—osteoporosis	1.03e-05	0.00024	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ADCY5—osteoporosis	9.55e-06	0.000223	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GPX1—osteoporosis	9.52e-06	0.000223	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MTHFR—osteoporosis	8.78e-06	0.000205	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—POMC—osteoporosis	8.29e-06	0.000194	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—POMC—osteoporosis	8.22e-06	0.000192	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—POMC—osteoporosis	7.02e-06	0.000164	CbGpPWpGaD
